The life sciences industry across Europe has enjoyed numerous growth opportunities over the past decade, both here and abroad, driven by ongoing innovation across the pharmaceutical, biotechnology, medical device, and nutrition sectors. However, organizations are dealing with increasingly complex regulatory, quality, and operational requirements. In addition, aligning with frameworks such as EMA submissions, GMP validation, ISO certification, and MDR readiness has been at the heart of driving successful product development and market access.
The commitment to satisfying regulatory requirements while deploying cross-functional programs that operationalize clinical operations, scale manufacturing, continuity of supply, and minimize risk exacerbates these pressures. This constellation of factors warrants a growing need for pure-play consulting and project management to navigate organizations through complex workflows while remaining efficient and maintaining oversight.
SIRE Life Sciences is a consultancy and project management partner for Europe’s life sciences ecosystem, founded in 2012 and headquartered in Haarlem, the Netherlands. The company provides interim management and structured project execution to support organizations with compliance, operational efficiency, and strategic growth. By combining staffing, consultancy, and tailored project delivery models, the company deploys professionals from various disciplines to guide companies through highly demanding regulatory frameworks toward accelerated innovation. Regulatory planning, quality assurance, clinical oversight, manufacturing optimization, and risk mitigation are all cornerstones of SIRE Life Sciences’ approach to ensure projects move forward in the timeliest manner possible while meeting compliance requirements.
A large part of the company’s work is related to regulatory compliance and dossier preparation. Consultants at SIRE Life Sciences assist organizations with EMA submissions by adapting regulatory documentation to meet European requirements. The firm also covers GMP implementation, inspection readiness, and validation of manufacturing processes. It offers advice on ISO quality frameworks applicable to both pharmaceuticals and medical devices. In these areas, close collaboration among various departments is expected, including quality, clinical operations, production, and supply chain teams. The company standardizes workflows and applies the known practices to minimize operational risks for an organization and keep up with changing regulatory standards.
In addition, SIRE Life Sciences provides operational and manufacturing program support. The project managers within the company manage process validation, equipment qualification, and scale-up production plans, many times in parallel with compliance activities. These include manufacturing efficiency optimization, data integrity implementation, and enhancement of operational effectiveness metrics. SIRE Life Sciences arranges cross-functional teams and applies stage-gate, agile, or hybrid project methodologies to ensure that initiatives proceed in a controlled manner, providing complete visibility into milestones, risk assessments, and deliverables. This model allows organizations to maintain alignment across multiple projects and ensure continuity under regulatory scrutiny.
Other core areas of the company’s involvement include clinical operations and pharmacovigilance. SIRE Life Sciences oversees clinical trial programs in site activation, vendor management, monitoring strategies, and documentation quality. Specialists ensure trial integrity while supporting risk-based pharmacovigilance activities, signal detection, and reporting in accordance with European regulations. This ensures timely study completion and compliance, supporting overall organizational objectives. Interim consultants for these projects are handpicked for their domain expertise and prior experience in similar European projects, enabling teams to ramp up quickly and deliver immediate impact.
Apart from regulatory and clinical operations, SIRE Life Sciences is involved in projects to rethink supply chain and manufacturing processes. Engineering and operational experts oversee production transfers, lean process implementations, serialization compliance, and increases in overall equipment effectiveness. By harmonizing cross-functional teams, the consultancy advises companies on expanding production capacity, ensuring that European standards are consistently upheld, and preparing them for inspection. These engagements are accompanied by risk-based reporting and project documentation, allowing management to maintain oversight.
The transparency, accountability, and measurability of outcomes are stressed in the firm’s project management methodology. Stage-gate frameworks provide phased project execution with regular checkpoints, while agile and hybrid approaches allow flexibility for iterative adjustments and rapid response to evolving conditions. Intrinsic to each engagement are reporting mechanisms, stakeholder alignment, and risk escalation protocols that ensure all elements of complex projects are tracked and mitigated. This is a structured yet adaptive approach that enables companies to pursue multiple regulatory, clinical, and operational objectives without compromising compliance or delivery standards.
Since its founding, SIRE Life Sciences has worked with organizations across the Netherlands and the broader European life sciences sector. With a network of over 375,000 professionals and experience in more than 4,000 successful placements, the firm can deploy interim specialists and project teams quickly. Such a scale means large projects, such as manufacturing expansions, clinical trials, or regulatory submissions, are supported by professionals whose expertise is verified, providing continuity and reducing reliance on external vendors. The consultancy integrates advisory and delivery functions into its model, helping organizations execute projects efficiently while remaining compliant with European regulations.
Industry recognition reflects the firm’s established presence and engagement in Europe’s life sciences ecosystem. SIRE Life Sciences has been listed in the Financial Times FT 1000 of Europe’s fastest-growing companies and has also received the FD Gazellen awards. The company has also been recognized by Global Health & Pharma through nominations. It won at the International Life Sciences and Private Healthcare Awards. These recognitions point out the firm’s sustained involvement in complex sector initiatives, with an operational footprint across consultancy, staffing, and project management services.
SIRE Life Sciences provides strategic and operational oversight, as well as compliance management. Through cross-functional project execution, regulatory strategy development, and interim management solutions, the consultancy guides organizations toward efficiency, innovation, and compliance within Europe’s life sciences landscape. Structured project management, domain expertise, and an extensive professional network together enable organizations to manage large-scale initiatives with minimum operational risk.
Founded by Jordy Stravers and Jan-Willem van Broekhoven, SIRE Life Sciences has built a reputation as a consultancy capable of handling complex European life sciences projects. Via interim management, cross-functional project delivery, and regulatory support, the company continues to address the sector’s increasing operational and compliance demands. Its methodologies and professional networks form the basis for scalable solutions that adhere to European regulatory frameworks, in support of the greater ecosystem of pharmaceutical, biotechnology, medical device, and nutrition organizations.
